Coronary
Clinical Indications and Science Learning Series
Indications and Patient Subsets
Episodes
Identifying the Highest Risk Secondary Prevention Patient Post PCI: What to Look For?
12 min.
Novel Solutions for High Bleeding Risk Patients
18 min.
Treatment of Patients With Diabetes and Diffuse Disease – Current Limitations
9 min.
PCI vs CABG for LMCA Disease: Synthesis of the Literature
9 min.
Complete Revascularization in Patients With STEMI and MVD: CV Outcomes, Quality of Life, and Future Directions
7 min.
Immediate Non-Culprit Lesion PCI Is the Way to Go!
6 min.
Staged Non-Culprit Lesion PCI Is Safer and Better for the Patient!
10 min.
STEMI State-of-the-Art: A Physiology-Guided Strategy!
5 min.
STEMI State-of-the-Art: An Imaging-Guided Strategy!
8 min.
Case Presentation 2: SCAD Patient – How to Revascularize With PCI If You Have to
11 min.
Intentional Coronary Revascularization Versus Conservative Therapy in Patients, who Underwent Successful Peripheral Artery Revascularization due to Critical Limb Ischemia - the INCORPORATE Randomized Clinical Trial
8 min.
DCB Update: Overview of Current Clinical and Anatomical Indications
7 min.
Position 2: Ischemia and Viability Assessment Remain the Key to Guiding Revascularization
11 min.
Position 1: Ischemia and Viability Testing Are Overrated – Clinical Judgement Should Guide Patient Management
7 min.
We Need More Data Following REVIVED: Unanswered Questions, Current and Future Trials
12 min.
Revascularization For Patients With Left Ventricular Dysfunction: Are The Trials Still Relevant After a Decade of GDMT and Device Therapy?
14 min.
Percutaneous Revascularization for Patients With Left Ventricular Dysfunction: REVIVED-BCIS2 – What Do We Know One Year On?
13 min.
State of the Art Left Main and Multivessel Revascularization in 2023: Where Does the Data Stand?
16 min.
Coronary Keynote Lecture: My Top Tips and Tricks for Saphenous Vein Graft Intervention
12 min.
Drug-Coated Balloon for Acute Coronary Syndromes: A Multicenter Randomized Non-inferiority Trial (DCB-ACS Trial)
13 min.
A Prospective, Multicenter, Randomized Trial Comparing Sirolimus-Coated Balloon with Paclitaxel-Coated Balloon in De-Novo Small Vessels: The TRANSFORM I Trial
19 min.
Causes for Angina Without Obstructive Coronary Disease
10 min.
How Important Is Complete Revascularization?
7 min.
STEMI with Multivessel Disease: Managing the Non-Culprit Vesel
3 min.
ACS with a Large Thrombus Burden: Thrombectomy Revisited ? Guidelines Recommendations
3 min.
Thrombectomy Case Presentation
5 min.
Does It Matter What Stent I Use in a HBR Patient?
8 min.
We Should Be Offering More Surgery to Patients With Complex Multivessel Disease
10 min.
A Clinical Cardiologist’s View on How to Choose Revascularization Strategies
9 min.
PCI in Patients With AF: The Risk and Benefit of Antithrombotic Therapy
7 min.
Coronary DCB in HBR Patients: An Alternative to DES?
6 min.
We Should Be Offering More PCI to Patients With Complex Multivessel Disease
5 min.
Complex and Higher Risk PCI: How Should It Be Defined and Who Should Be Doing It?
10 min.
Hard Outcomes Prevail
7 min.
Get With the Program: Patient-Oriented Outcomes Are Key
7 min.
Revascularization in LV Systolic Dysfunction: Revived or Dead?
12 min.
Management of Coronary Artery Disease in CLTI? Is That the Ticket?
7 min.